立弘生化科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:18 AM
最後更新時間 2025/07/18 , 07:18 AM
負責人
Yang,Zheng-Li
統一編號
12971536
成立日期
2001/12/25
資本額
NT$1,200,000,000
實收資本額
NT$960,241,190
股票代號
1780
電話
02-27030209
地址
13F, No. 71, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City, 106, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Yang,Zheng-Li Chairman 18.72% KING CORE ELECTRONICS INC.
Zhuang,Yong-Shun Director 0.00%
MEGA INTERNATIONAL COMMERCIAL BANK CO., LTD. Director 12.92%
Luo,Li-Fen Director 1.04%
He,Shi-Jun Director 0.52%
Gong,Rong-Min Director 18.72% KING CORE ELECTRONICS INC.
Guo,Tu-Mu Independent Director 0.00%
Xu,Ying-Jie Independent Director 0.00%
Chen,Qing-Kun Independent Director 0.00%
營業項目
  • Wholesale of Chemical Materials and Chemical Products(462099)
  • Manufacture of Other Food Products Not Elsewhere Classified(089999)
  • Wholesale of Other Food(454999)
  • 公司歷程
  • Change Person in Charge to Yang,Zheng-Li
    2014/07/29
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2024 2023 2022
    Operating income 806,917 720,431 716,746
    Operating cost 548,534 473,992 445,700
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 258,383 246,439 271,046
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 258,383 246,439 271,046
    Operating expenses 170,268 157,725 171,267
    Other gain (loss), net - - -
    Operating profit (loss) 88,115 88,714 99,779
    Non-operating income and expenses 41,920 33,670 85,256
    Net profit (loss) before tax 130,035 122,384 185,035
    Income tax expense (benefits) 29,096 24,972 38,294
    Net profit (loss) of ongoing business for the current period 100,939 97,412 146,741
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 100,939 97,412 146,741
    Other comprehensive profit (loss), net 2,912 -3,840 2,216
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 103,851 93,572 148,957
    Net profit (loss) attributable to owners of parent company 100,939 97,412 146,741
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests - - -
    Comprehensive profit (loss) attributable to owners of parent company 103,851 93,572 148,957
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests - - -
    Basic earnings per share (yuan) 1 1 1
    項目 2024 2023 2022
    Net cash inflow (outflow) from operating activities 223,793 137,617 164,274
    Net cash inflows (outflows) from investing activities 70,546 -40,939 219,016
    Net cash inflow (outflow) from financing activities 64,940 -158,327 -461,998
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 558 393 1,070
    Increase (decrease) in cash and cash equivalents in the current period 359,837 -61,256 -77,638
    Beginning balance of cash and cash equivalents 618,494 679,750 757,388
    Ending balance of cash and cash equivalents 978,331 618,494 679,750
    項目 2024 2023 2022
    Current asset 1,663,096 1,456,872 1,534,936
    Non-current asset 593,759 622,032 648,080
    Total asset 2,256,855 2,078,904 2,183,016
    Current liability 996,249 828,687 894,771
    Non-current liability 65,075 81,429 104,633
    Total liability 1,061,324 910,116 999,404
    share capital 960,241 957,848 953,846
    Equity - secruity token - - -
    capital reserve 9,654 7,738 5,674
    retained earning 231,310 209,279 229,880
    Other equity -5,674 -6,077 -5,788
    Treasury stock - - -
    Total equity attributable to owners of parent company 1,195,531 1,168,788 1,183,612
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests - - -
    Total Equity 1,195,531 1,168,788 1,183,612
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 12 12 12
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • 立弘生化科技股份有限公司標章
  • Lycotene
  • Lutene
  • Canthatene
  • 康泰紅
  • 康泰黃
  • Altratene
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。